REG - Transense Technlgy - AIM Rule 17 Schedule Two (g) update

Transense TechnologiesAnnouncement

20/01/2025 13:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250120:nRST9939Ta&default-theme=true

RNS Number : 9939T  Transense Technologies PLC  20 January 2025

20 January 2025

 

Transense Technologies plc

("Transense" or the "Company")

 

AIM Rule 17 Schedule Two (g) update

 

Transense Technologies Plc (AIM: TRT), the provider of specialist sensing
solutions and measurement systems, announces the following information
relating to directors' disclosures under Rule 17 and Schedule 2(g) of the AIM
Rules for Companies.

 

Nigel Rogers, Chairman of Transense, was previously a director of TT
Electronics Wireless Devices Limited (previously known as Hale End 999 Ltd)
until 30 April 2011. Craig Wilson, Non-Executive Director, was a director of
Williams Advanced Engineering Deutschland (GmbH) until January 2024. Craig
Wilson was also a director of 01194903 Limited (also known as T.W.R. Group
Limited) which went into administrative receivership in February 2003.

 

For further information please visit www.transense.com or contact:

 

 Transense Technologies plc                                     Via Investor Relations

 Nigel Rogers (Executive Chairman)                              (see below)

 Ryan Maughan (Managing Director)

 Melvyn Segal (Chief Financial Officer)
 Allenby Capital (Nominated Adviser and Broker)                 Tel: +44 (0)20 3328 5656

 Jeremy Porter / George Payne (Corporate Finance)

 Stefano Aquilino / Tony Quirke (Sales and Corporate Broking)
 Investor Relations                                             Tel: +44 (0)1869 238380 investor.relations@transense.co.uk

                                                              (mailto:investor.relations@transense.co.uk)
 Anice McNamee

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on
AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company
develops and supplies advanced sensor technology and measurement solutions
used by some of the world's leading companies to improve performance,
efficiency, and safety in demanding, mission critical applications. Transense
currently operates through two active business segments:

 

·    SAWsense - designs, supplies and licences advanced sensor solutions
based on proven, patent protected Surface Acoustic Wave (SAW) technology to
world leading companies in aerospace, automotive, and industrial machinery
(including robotics), enabling improved efficiency and performance of their
products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied,
Airbus and several other confidential Tier One automotive, aerospace and
industrial machinery suppliers.

 

·    Translogik - develops smart, connected commercial vehicle tyre
inspection equipment to many of the world's leading tyre suppliers, fleet
operators and service centres. Enabling accurate measurement and digital
capture of safety-critical tyre condition data, used to reduce operating
costs, improve safety and provide audit records for regulatory compliance. Key
customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli),
and leading independent providers of vehicle fleet maintenance management
software.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack -
a tyre monitoring system for off-highway vehicles that was developed by
Translogik. The associated sales, support and development infrastructure were
sold to Bridgestone Corporation, the world's largest tyre producer, in June
2020, and the intellectual property was licensed exclusively to Bridgestone
under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/ (https://www.transense.com/)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNSEWFDSEISEEF